Steven D. Rubin - 24 Jun 2025 Form 4 Insider Report for Niagen Bioscience, Inc. (NAGE)

Role
Director
Signature
/s/ Jeong James Lee, Attorney-in-Fact
Issuer symbol
NAGE
Transactions as of
24 Jun 2025
Net transactions value
$0
Form type
4
Filing time
25 Jun 2025, 20:29:27 UTC
Previous filing
29 May 2025
Next filing
22 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rubin Steven D Director 10900 WILSHIRE BLVD. SUITE 600, LOS ANGELES /s/ Jeong James Lee, Attorney-in-Fact 25 Jun 2025 0001381874

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NAGE Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 24 Jun 2025 Common Stock 20,000 $14.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests 100% on June 24, 2026.